ir.recordcm.com
Record Currency Management - Investors centre
Record Currency Management - Home. Financial information and reporting. Record is a specialist currency manager and provider of currency hedging services for institutional clients. Founded in 1983, Record has established a market leading position as a currency manager. Specifically, the Group has a leading position in managing Dynamic Hedging and Currency for Return for institutional clients. 44 (0)1753 852 222. Privacy and Cookie policy.
ir.recropharma.com
Investor Relations :: Recro Pharma, Inc. (REPH)
Recro Pharma owns and operates an 97,000 square foot, DEA-licensed facility that manufactures five commercial products that are commercialized by partners and receives royalties associated with the sales of these products.
ir.rediff.com
Home | Investor Information
Rediff’s Secure Internet Platform wins CIO’s Choice 2016. LJ Road # 1, Mahim (West). 169; 2018 Rediff.com US.
ir.redknee.com
Investor Relations | Investor Overview | Redknee
2016 In the Media. 2015 In the Media. 2014 In the Media. 2013 In the Media. Middle East and Africa. Railway SIM Profile Management. Railway Next Generation IN. Railway Subscription Management and Data Provisioning. Managed Services and Cloud Services. Stock Quote and Chart. Management and Board of Directors. Create New Business Models. Advance the Customer Experience. Live in Action Demos. Live in Action Demos. Real-time Monetization for a Real-time World. Redknee monetizes today’s digital world, providi...
ir.refire-online.com
home ~ REFIRE online ~ Real Estate Intelligence Report - Europe
Declaration of PropertyCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of PropertyItem: setField() should be compatible with Item: setField($field, $value, $safe = true) in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of DBFSCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class...
ir.regenxbio.com
Investor Overview - Investors - REGENXBIO
160; 0.20. Data as of 01/12/17 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. REGENXBIO Provides Year-End 2016 Corporate Update. REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors. ROCKVILLE, Md. and CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) - REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based ...On track to d...
ir.regions.com
Regions Financial Corporation - Investor Relations
Spectrum Card - Employee. Spectrum Card - Employer. 4:02 PM ET, 03/29/18. Regions is scheduled to release 1Q18 results on Friday April 20, 2018. Live teleconference and webcast beginning at 11am EST. Rarr; Learn More. Listen to the replay and read the transcript of Regions Executives present at the 2018 Credit Suisse Financial Services Conference. Rarr; Learn More. Website Terms of Use.
ir.regulusrx.com
Regulus Therapeutics Inc. - Investor Relations
Skip to primary content. Skip to secondary content. Road to the Clinic. Biology & Pharmacology. 4:00 PM ET on Aug 17, 2015. Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting. RNA therapeutics pipeline entering clinical development, an emerging. RNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the. RNA field have enabled the formation ...
ir.rehabcare.com
Rehabcare : Overview
Founded in 1982, RehabCare is a leading provider of services across the post-acute continuum of care, operating programs and hospitals nationwide. RehabCare is a publicly traded company, listed on the NYSE under the symbol RHB, and is included in the Russell 2000 and Standard and Poor’s Small Cap 600 Indices. Could not find file ' aws.nasdaqomx.com irweb content3 IRXMLDATA 68 68419 Quotes.xml'. RehabCare Reports First Quarter 2011 Results. RehabCare To Announce First Quarter 2011 Results. Replication or ...
ir.relmada.com
Investor Relations :: Relmada Therapeutics, Inc. (RLMDD)
REL-1017 (dextromethadone, d-Methadone). Cash position on March 31, 2015. Headcount as of December 31, 2014. Common stock outstanding at May 15, 2015. Aug 17, 2015. Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist. Sign Up for E-Mail Alerts. Be the first to receive breaking news. Mar 31, 2015. Officers & Directors. Slide" data-cycle-swipe="true" data-cycle-timeout= 0. Douglas J. Beck. Michael D. Becker. Dr Mangano has ...
